These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 36285345)
41. Amyotrophic lateral sclerosis risk for spinocerebellar ataxia type 2 ATXN2 CAG repeat alleles: a meta-analysis. Neuenschwander AG; Thai KK; Figueroa KP; Pulst SM JAMA Neurol; 2014 Dec; 71(12):1529-34. PubMed ID: 25285812 [TBL] [Abstract][Full Text] [Related]
42. More than a co-incidence? Comment on: Amyotrophic lateral sclerosis is over-represented in two Huntington's disease brain bank cohorts: further evidence to support genetic pleiotropy of pathogenic HTT gene expansion. Bakels HS; Feleus S; van Dis V; de Bot ST Acta Neuropathol; 2023 Feb; 145(2):257-258. PubMed ID: 36335527 [No Abstract] [Full Text] [Related]
43. C9orf72 hexanucleotide repeat expansions as the causative mutation for chromosome 9p21-linked amyotrophic lateral sclerosis and frontotemporal dementia. Daoud H; Suhail H; Sabbagh M; Belzil V; Szuto A; Dionne-Laporte A; Khoris J; Camu W; Salachas F; Meininger V; Mathieu J; Strong M; Dion PA; Rouleau GA Arch Neurol; 2012 Sep; 69(9):1159-63. PubMed ID: 22964911 [TBL] [Abstract][Full Text] [Related]
44. Clinical and Molecular Findings of Intermediate Allele Carriers in the HTT Gene from the Mexican Mestizo Population. Ramírez-García MÁ; Dávila-Ortiz de Montellano DJ; Martínez-Ruano L; Ochoa-Morales A; Romero-Hidalgo S; Zenteno JC; Yescas-Gómez P Neurodegener Dis; 2022; 22(1):34-42. PubMed ID: 35926480 [TBL] [Abstract][Full Text] [Related]
45. Repeat RNA expansion disorders of the nervous system: post-transcriptional mechanisms and therapeutic strategies. Schwartz JL; Jones KL; Yeo GW Crit Rev Biochem Mol Biol; 2021 Feb; 56(1):31-53. PubMed ID: 33172304 [TBL] [Abstract][Full Text] [Related]
46. RNA toxicity induced by expanded CAG repeats in Huntington's disease. Martí E Brain Pathol; 2016 Nov; 26(6):779-786. PubMed ID: 27529325 [TBL] [Abstract][Full Text] [Related]
51. Genetic screening for Huntington disease phenocopies in Sweden: A tertiary center case series focused on short tandem repeat (STR) disorders. Paucar M; Laffita-Mesa J; Niemelä V; Malmgren H; Nennesmo I; Lagerstedt-Robinson K; Nordenskjöld M; Svenningsson P J Neurol Sci; 2023 Aug; 451():120707. PubMed ID: 37379724 [TBL] [Abstract][Full Text] [Related]
52. Chromosomal instability during neurogenesis in Huntington's disease. Ruzo A; Croft GF; Metzger JJ; Galgoczi S; Gerber LJ; Pellegrini C; Wang H; Fenner M; Tse S; Marks A; Nchako C; Brivanlou AH Development; 2018 Jan; 145(2):. PubMed ID: 29378824 [TBL] [Abstract][Full Text] [Related]
53. Biallelic mutations in huntington disease: A new case with just one affected parent, review of the literature and terminology. Uhlmann WR; Peñaherrera MS; Robinson WP; Milunsky JM; Nicholson JM; Albin RL Am J Med Genet A; 2015 May; 167A(5):1152-60. PubMed ID: 25736541 [TBL] [Abstract][Full Text] [Related]
54. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys. Cho IK; Yang B; Forest C; Qian L; Chan AWS PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183 [TBL] [Abstract][Full Text] [Related]
55. Clinical phenotype in carriers of intermediate alleles in the huntingtin gene. Savitt D; Jankovic J J Neurol Sci; 2019 Jul; 402():57-61. PubMed ID: 31103960 [TBL] [Abstract][Full Text] [Related]